GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Cardiff Oncology, Inc. - Common Stock (CRDF)

Symbol: CRDF on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$4,280,748	1,523,015	-20,305	-1.3%	$2.81	Q4 2025
30 Sep 2025	0%	+0%	$3,180,068	1,543,320	+44,482	+3%	$2.06	Q3 2025
30 Jun 2025	0%	+0%	$4,722,511	1,498,838	+104,409	+7.5%	$3.15	Q2 2025
31 Mar 2025	0%	+0%	$4,379,271	1,394,429	+411,551		$3.14	Q1 2025
31 Dec 2024	0%	+0%	$4,266,268	982,878	+54,646	+5.9%	$4.34	Q4 2024
30 Sep 2024	0%	+0%	$2,478,666	928,232	+17,557	+1.9%	$2.67	Q3 2024
30 Jun 2024	0%	+0%	$2,021,946	910,675	+475,842	+109%	$2.22	Q2 2024
31 Mar 2024	0%	+0%	$2,322,585	434,833	+10,727	+2.5%	$5.34	Q1 2024
31 Dec 2023	0%	+0%	$627,823	424,106	+31,799	+8.1%	$1.48	Q4 2023
30 Sep 2023	0%	+0%	$545,458	392,307	+11,157	+2.9%	$1.39	Q3 2023
30 Jun 2023	0%	-0%	$560,290	381,150	-32,352	-7.8%	$1.47	Q2 2023
31 Mar 2023	0%	0%	$682,278	413,502	0		$1.65	Q1 2023
31 Dec 2022	0%	0%	$578,000	413,502	-870	-0.21%	$1.40	Q4 2022
30 Sep 2022	0%	+0%	$638,000	414,372	+2,262	+0.55%	$1.54	Q3 2022
30 Jun 2022	0%	-0%	$906,000	412,110	-257,719	-38%	$2.20	Q2 2022
31 Mar 2022	0%	+0%	$1,661,000	669,829	+24,745	+3.8%	$2.48	Q1 2022
31 Dec 2021	0%	+0%	$3,876,000	645,084	+62,927	+11%	$6.01	Q4 2021
30 Sep 2021	0%	+0%	$3,877,000	582,157	+67,176	+13%	$6.66	Q3 2021
30 Jun 2021	0%	+0%	$3,424,000	514,981	+306,526	+147%	$6.65	Q2 2021
31 Mar 2021	0%	+0%	$1,930,000	208,455	+5,569	+2.7%	$9.26	Q1 2021
31 Dec 2020	0%	+0%	$3,649,000	202,886	+96,327	+90%	$17.99	Q4 2020
30 Sep 2020	0%	+0%	$1,512,000	106,559	+66,283	+165%	$14.19	Q3 2020
30 Jun 2020	0%	+0%	$201,000	40,276	+40,276	NEW	$4.99	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.